Matt is the Chief Investment Officer of Boston Common’s international equity strategies. In this capacity, he works closely with analyst and portfolio construction teams to create internationally focused portfolios. He also communicates key aspects of these strategies, including ESG and impact criteria, security and sector positioning, macroeconomic outlook, and performance, with clients and prospects. On the research side, Matt currently serves as a healthcare analyst, where he focuses primarily on pharmaceuticals and biotech. He previously covered financial services. Matt is a member of Boston Common’s Board of Directors.
From 1997 to 2001, Matt worked at Dodge & Cox in San Francisco, where he covered banks and REITs and helped the firm launch its international mutual fund. He began his career at State Street Research and Management in Boston in 1995.
Matt received his AB cum laude in Economics and International Studies from Colby College and has an MA in International Relations from Johns Hopkins’ School of Advanced International Studies (SAIS), where he specialized in emerging markets and worked on development consulting projects in Mexico and Ecuador. Matt has lived in Spain and has traveled extensively throughout Europe, Latin America, and Asia. Matt lives on Massachusetts’ North Shore with his wife and two daughters. He enjoys traveling, hiking, reading, and tennis and currently serves on the board of MicroLoan Foundation USA.